Loading...
HomeServicesRisk-based Monitoring

Risk-basedMonitoring

Clinical monitoring ensures the integrity, accuracy, patient safety and compliance of your clinical trial. We provide thorough and proactive monitoring services, protecting your data quality and ensuring strict adherence to Good Clinical Practice (GCP), regulatory and protocol requirements.

Our service includes

Risk-Based Monitoring (RBM)

Implementation of tailored, risk-based strategies that optimize monitoring activities, ensuring maximum efficiency.

Site Initiation Visit (SIV), Site Close-out visits (COV) and trainings

Preparation of visits and trainings for study teams, systematic completion of all monitoring activities, ensuring accurate data verification, resolution of queries, and thorough documentation review.

On-site and Remote Monitoring Visits

In accordance with the monitoring plan, we review trial sites to verify protocol adherence, data accuracy, and regulatory compliance, while ensuring that any identified issues are addressed in a timely and documented manner.

Data Verification and Quality Assurance

Rigorous verification of clinical data to confirm consistency, reliability, and accuracy, significantly enhancing the quality of the final datasets.

Investigator and Site Support

Dedicated support to site staff, proactively resolving operational issues and reinforcing protocol adherence throughout the trial lifecycle.

With GALSER, your trials benefit from precise, structured monitoring, safeguarding your clinical data quality and regulatory compliance from start to finish.

Faq

Business professional

Feedback from our clients

A remarkable project leader who managed to deliver a high-quality protocol in a very short time
Swiss University Hospital
Principal Investigator - Initiated Investigator Trial

01

/05

The GALSER team guided us through the Swiss regulatory process with clear advice and great responsiveness. Their support made the entire submission much easier than we anticipated.
Mid-Size Company​
Director Clinical Operations Europe

02

/05

We were impressed by GALSER’s strong relationships with the study sites and their ability to keep things moving despite the usual challenges. It really helped us stay on track
Big Pharma​
Head of Global Clinical Development

03

/05

Your level of detail and expertise really stand out. It’s been a real pleasure working together!
Start-Up​
CMO

04

/05

GALSER team has shown a great mix of professionalism, flexibility/adaptability and profound knowledge of the human research landscape in Switzerland
Big Pharma​
Medical Affairs Associate

05

/05

Loading...